Клувот

Клувот is a human coagulation factor XIII concentrate used to support blood clotting processes. This intravenous therapy is prescribed for patients with congenital or acquired factor XIII deficiency. Always consult a healthcare professional before use.

Клувот is used to treat and prevent bleeding episodes in patients with factor XIII deficiency, a rare blood disorder that affects clotting. It may also be used perioperatively to reduce bleeding risk during surgical procedures. Patients often ask, what is Клувот used for, and it is primarily indicated for managing this specific clotting disorder.

Клувот works by replacing or supplementing the deficient factor XIII in the bloodstream, helping to stabilize blood clots and reduce bleeding episodes. Patients may notice improved clotting function over time with regular use. The effects vary based on individual response and underlying condition.

Клувот should be handled with care to avoid contamination or infection during preparation and administration. It is important to follow sterile techniques and use only as directed by a healthcare provider. Patients with known allergies to human blood products should exercise caution.

No specific drug interactions have been widely documented for Клувот. However, as with any intravenous therapy, caution is advised when combining with other medications that affect blood clotting. Patients should inform their healthcare provider about all medications they are taking.